Literature DB >> 8557264

Congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis transmembrane regulator (CFTR): correlation between genotype and phenotype.

V Dumur1, R Gervais, J M Rigot, E Delomel-Vinner, B Decaestecker, J J Lafitte, P Roussel.   

Abstract

To assess better the link between congenital bilateral absence of the vas deferens (CBAVD) and cystic fibrosis (CF), we compared sweat chloride values, analysis of the CFTR intron 8 poly(T) tract length and analysis of 10 exons in a population of 38 patients with CBAVD. The data indicate that this population can be divided into three groups of patients. In the first group of 15 patients with abnormal sweat chloride (> 60 mmol/l), the frequency of CF mutations is high. In the second group of 18 patients with equivocal sweat chloride (between 40 and 60 mmol/l), the frequency of the 5T variant is high; 6 patients have a delta F508 mutation and a 5T variant and 1 patient is homozygous for the 5T variant; a 5T variant has been detected in 3 other patients, and a delta F508 mutation in another patient. A third group of 5 patients is probably not related to CF: these patients have other congenital abnormalities of the urogenital tract, low chloride values (< 40 mmol/l) and apparently no abnormality of the CF gene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557264     DOI: 10.1007/bf00218824

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Sweat sodium and chloride concentrations--essential criteria for the diagnosis of cystic fibrosis in adults.

Authors:  S K Hall; D E Stableforth; A Green
Journal:  Ann Clin Biochem       Date:  1990-07       Impact factor: 2.057

2.  Cystic fibrosis diagnosed after age 13. Twenty-five teenage and adult patients including three asymptomatic men.

Authors:  R C Stern; T F Boat; C F Doershuk; A S Tucker; R B Miller; L W Matthews
Journal:  Ann Intern Med       Date:  1977-08       Impact factor: 25.391

3.  High frequency of the R117H cystic fibrosis mutation in patients with congenital absence of the vas deferens.

Authors:  R Gervais; V Dumur; J M Rigot; J J Lafitte; P Roussel; M Claustres; J Demaille
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

4.  Congenital bilateral absence of vas deferens in the absence of cystic fibrosis.

Authors:  A Augarten; Y Yahav; B S Kerem; D Halle; J Laufer; A Szeinberg; J Dor; S Mashiach; E Gazit; I Madgar
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

5.  The electrolyte composition of normal adult sweat.

Authors:  C A Coltman; R J Atwell
Journal:  Am Rev Respir Dis       Date:  1966-01

6.  Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  J Zielenski; R Rozmahel; D Bozon; B Kerem; Z Grzelczak; J R Riordan; J Rommens; L C Tsui
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

7.  Variation of sweat sodium and chloride with age in cystic fibrosis and normal populations: further investigations in equivocal cases.

Authors:  J M Kirk; M Keston; I McIntosh; S al Essa
Journal:  Ann Clin Biochem       Date:  1992-03       Impact factor: 2.057

8.  Compound heterozygosity for the delta F508 and F508C cystic fibrosis transmembrane conductance regulator (CFTR) mutations in a patient with congenital bilateral aplasia of the vas deferens.

Authors:  D Meschede; A Eigel; J Horst; E Nieschlag
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

9.  Cystic fibrosis mutations impair the fertilization rate of epididymal sperm from men with congenital absence of the vas deferens.

Authors:  P Patrizio; T Ord; S J Silber; R H Asch
Journal:  Hum Reprod       Date:  1993-08       Impact factor: 6.918

10.  Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium.

Authors:  C S Chu; B C Trapnell; J J Murtagh; J Moss; W Dalemans; S Jallat; A Mercenier; A Pavirani; J P Lecocq; G R Cutting
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

View more
  8 in total

1.  Update and Review: Cystic Fibrosis.

Authors:  T Brown; E L Schwind
Journal:  J Genet Couns       Date:  1999-06       Impact factor: 2.537

2.  Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.

Authors:  Sunil Sheth; Julie C Shea; Michele D Bishop; Sanjiv Chopra; Meredith M Regan; Emily Malmberg; Carolyn Walker; Ryan Ricci; Lap-Chee Tsui; Peter R Durie; Julian Zielenski; Steven D Freedman
Journal:  Hum Genet       Date:  2003-06-03       Impact factor: 4.132

Review 3.  Micro- and macrorheology of mucus.

Authors:  Samuel K Lai; Ying-Ying Wang; Denis Wirtz; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2009-01-03       Impact factor: 15.470

4.  Genetic analysis and intracytoplasmic sperm injection outcomes of Chinese patients with congenital bilateral absence of vas deferens.

Authors:  Hongbo Cheng; Shenmin Yang; Qingxia Meng; Bo Zheng; Yidong Gu; Luyun Wang; Tao Song; Chunlu Xu; Gaigai Wang; Mutian Han; Liyan Shen; Jie Ding; Hong Li; Jun Ouyang
Journal:  J Assist Reprod Genet       Date:  2022-02-04       Impact factor: 3.412

Review 5.  Human Molecular Genetics and the long road to treating cystic fibrosis.

Authors:  Ann Harris
Journal:  Hum Mol Genet       Date:  2021-10-01       Impact factor: 5.121

6.  Survey of CF mutations in the clinical laboratory.

Authors:  Klaus Huber; Borka Mirkovic; Rhea Nersesian; Angela Myers; Randall Saiki; Kurt Bauer
Journal:  BMC Clin Pathol       Date:  2002-11-19

7.  Bactericidal/permeability-increasing protein originates in both the testis and the epididymis and localizes in mouse spermatozoa.

Authors:  Zhong-Ping Zhou; Xiao-Yu Xia; Qiang-Su Guo; Chen Xu
Journal:  Asian J Androl       Date:  2014 Mar-Apr       Impact factor: 3.285

8.  Sharing genetic variants with the NGS pipeline is essential for effective genomic data sharing and reproducibility in health information exchange.

Authors:  Jeong Hoon Lee; Solbi Kweon; Yu Rang Park
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.